FIVE PRIME THERAPEUTICS, INC. Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIVE PRIME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in FIVE PRIME THERAPEUTICS, INC. for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | A | 45.38 | 101,250 | 4,594,725 | 101,250 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Grant | A | 0.00 | 16,875 | 0 | 423,286 | 406.4 K to 423.3 K (+4.15 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Gift | G | 0.00 | 22,416 | 0 | 406,411 | 428.8 K to 406.4 K (-5.23 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Option Exercise | A | 45.38 | 30,000 | 1,361,400 | 30,000 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Grant | A | 0.00 | 14,531 | 0 | 123,057 | 108.5 K to 123.1 K (+13.39 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Grant | A | 0.00 | 5,625 | 0 | 108,526 | 102.9 K to 108.5 K (+5.47 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 45.38 | 45,000 | 2,042,100 | 45,000 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 5,768 | 0 | 94,902 | 89.1 K to 94.9 K (+6.47 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 10,310 | 0 | 89,134 | 78.8 K to 89.1 K (+13.08 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Option Exercise | A | 45.38 | 36,920 | 1,675,430 | 36,920 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Grant | A | 0.00 | 5,323 | 0 | 189,881 | 184.6 K to 189.9 K (+2.88 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Grant | A | 0.00 | 9,516 | 0 | 184,557 | 175 K to 184.6 K (+5.44 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Borges Luis | SVP, Research | Option Exercise | A | 45.38 | 25,000 | 1,134,500 | 25,000 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Borges Luis | SVP, Research | Grant | A | 0.00 | 7,031 | 0 | 82,972 | 75.9 K to 83 K (+9.26 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Borges Luis | SVP, Research | Grant | A | 0.00 | 5,625 | 0 | 75,941 | 70.3 K to 75.9 K (+8.00 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | A | 45.38 | 22,500 | 1,021,050 | 22,500 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Grant | A | 0.00 | 7,031 | 0 | 12,656 | 5.6 K to 12.7 K (+125.00 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Grant | A | 0.00 | 5,625 | 0 | 5,625 | 0 to 5.6 K |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Option Exercise | A | 45.38 | 25,000 | 1,134,500 | 25,000 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Grant | A | 0.00 | 7,031 | 0 | 95,420 | 88.4 K to 95.4 K (+7.95 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Grant | A | 0.00 | 5,625 | 0 | 88,389 | 82.8 K to 88.4 K (+6.80 %) |
| Feb 01 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.65 | 500 | 5,825 | 21,500 | |
| Feb 01 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 46.17 | 500 | 23,085 | 0 | 500 to 0 (-100.00 %) |
| Feb 01 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 500 | 5,825 | 500 | 0 to 500 |